The Week In... Pharma (04-08/03)

New biosimilar launches in the UK, campaigners say Donald Trump’s Brexit trade plan will damage the NHS, and fake medications are “easily” bought on Facebook. These are some of the top stories making headlines across pharma this week!

In the midst of the US administration’s objectives for a post-Brexit trade deal with the UK is a section calling for “procedural fairness” for pharmaceuticals, which is raising hackles in some quarters.

Napp Pharmaceuticals has launched Pelmeg in the UK, marking the group's first launch of a product developed by Cinfa Biotech, acquired by the Mundipharma network of independent associated companies in October last year.